Table 2.
Symptoms | Before COVID-19, n (%) | 12 weeks after COVID-19, n (%) | Long COVID cases, n out of N = 2507 | Proportion of new Long COVID cases, [95% CI] |
---|---|---|---|---|
Prolonged Generalized Weakness | 0 | 788; 31.4% | 533 | 0.21 [0.19-0.22] |
Fatigue | 132; 5.3% | 765; 30.5% | 475 | 0.18 [0.17-0.20] |
Sleep problems or disturbance | 0 | 407; 16.2% | 407 | 0.16 [0.14-0.17] |
Cough | 24; 1% | 398; 15.9% | 374 | 0.14 [0.13-0.16] |
Muscle pain | 47; 1.9% | 419; 16.7% | 372 | 0.14 [0.13-0.16] |
General Arthralgia | 44; 1.8% | 359; 14.3% | 315 | 0.12 [0.11-0.13] |
Anxiety based on the YRS scale | 68; 2.7% | 375; 15% | 307 | 0.12 [0.10-0.13] |
Depression based on the YRS scale | 67; 2.7% | 373; 14.9% | 306 | 0.12 [0.10-0.13] |
The problem with playing a social role | 61; 2.4% | 364; 14.5% | 303 | 0.12 [0.10-0.13] |
Headache | 19; 0.8% | 308; 12.3% | 289 | 0.11 [0.10-0.12] |
The problem in Activities of Daily Living | 48; 1.9% | 301; 12% | 253 | 0.10 [0.08-0.11] |
Dizziness | 0 | 272; 10.8% | 272 | 0.10 [0.09-0.12] |
Prolonged Fever | 0 | 246; 9.8% | 246 | 0.09 [0.08-0.11] |
Memory problem | 28; 1.1% | 257; 10.3% | 229 | 0.09 [0.08-0.10] |
Problem with personal care | 38; 1.5% | 265; 10.6% | 227 | 0.09 [0.07-0.10] |
Problem in Concentration | 34; 1.4% | 250; 10% | 216 | 0.08 [0.07-0.09] |
Breathlessness or Dyspnea | 116; 4.6% | 321; 12.8% | 205 | 0.08 [0.07-0.09] |
Mobility problem | 41; 1.6% | 238; 9.5% | 197 | 0.07 [0.06-0.08] |
Palpitation | 0 | 150; 6% | 150 | 0.05 [0.05-0.06] |
Chest pain | 11; 0.4% | 104; 4.1% | 93 | 0.03 [0.03-0.04] |
Skin Rash | 0 | 66; 2.6% | 66 | 0.02 [0.02-0.03] |
Swallowing and feeding problem | 0 | 30; 1.2% | 30 | 0.01 [0.008-0.01] |
Communication problem | 14; 0.6% | 42; 1.7% | 28 | 0.01 [0.007-0.01] |
Voice change | 6; 0.2% | 21; 0.8% | 15 | 0.006 [0.003-0.009] |
Problem with executing a plan | 6; 0.2% | 22; 0.9% | 16 | 0.006 [0.003-0.01] |
PTSD based on the YRS scale | 4; 0.2% | 20; 0.8% | 16 | 0.006 [0.003-0.01] |
Abdominal Pain | 6; 0.2% | 20; 0.8% | 14 | 0.005 [0.003-0.009] |
Noisy breathing | 6; 0.2% | 14; 0.6% | 8 | 0.003 [0.001-0.006] |
Bladder control problem | 5; 0.2% | 7; 0.3% | 2 | 0.001 [0.0001-0.002] |
Bowel control problem | 4; 0.2% | 5; 0.2% | 1 | 0.001 [0.00001-0.002] |
Long COVID defined according to WHO working group clinical criteria;
C19-YRS, COVID-19 Yorkshire Rehabilitation Scale; PTSD, Post-Traumatic Stress Disorder;